Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment. Anticancer Drugs. 2003 Oct; 14(9):669-82.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.